Qiangbo Zhang
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
Journal: Molecular cancer
Published: January 12, 2026
FLT3 is associated with dendritic cell infiltration, tertiary lymphoid structure construction, and predict response to checkpoint inhibitors immunotherapy in solid cancers.
Journal: Scientific reports
Published: November 09, 2024
Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2.
Journal: Cancer letters
Published: July 07, 2023
Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment.
Journal: Aging
Published: April 08, 2021
Prognostic role of miR-760 in hepatocellular carcinoma.
Journal: Oncology letters
Published: March 07, 2018
Maintenance of stemness is associated with the interation of LRP6 and heparin-binding protein CCN2 autocrined by hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 27, 2017
CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.
CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.
Journal: Scientific reports
Published: February 21, 2017
Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice.
Journal: Biomarkers in medicine
Published: November 23, 2016
The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.
Journal: Biochemical and biophysical research communications
Published: May 15, 2016
YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
Journal: Molecular cancer
Published: August 03, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026